Global PD-1 and PD-L1 Inhibitors Market Growth 2023-2028

Report ID: 1169724 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Country/Region, 2017, 2022 & 2028
    2.2 PD-1 and PD-L1 Inhibitors Segment by Type
        2.2.1 Humanized IgG1(Immunoglobulin 1)
        2.2.2 Humanized IgG4(Immunoglobulin 5)
        2.2.3 Cytokine
    2.3 PD-1 and PD-L1 Inhibitors Sales by Type
        2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
        2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Type (2017-2022)
        2.3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2017-2022)
    2.4 PD-1 and PD-L1 Inhibitors Segment by Application
        2.4.1 Oral
        2.4.2 Subcutaneous Injection
    2.5 PD-1 and PD-L1 Inhibitors Sales by Application
        2.5.1 Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2017-2022)
        2.5.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Application (2017-2022)
        2.5.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2017-2022)
3 Global PD-1 and PD-L1 Inhibitors by Company
    3.1 Global PD-1 and PD-L1 Inhibitors Breakdown Data by Company
        3.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Company (2020-2022)
        3.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2022)
    3.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Company (2020-2022)
        3.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2022)
        3.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2022)
    3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Company
    3.4 Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Location Distribution
        3.4.2 Players PD-1 and PD-L1 Inhibitors Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for PD-1 and PD-L1 Inhibitors by Geographic Region
    4.1 World Historic PD-1 and PD-L1 Inhibitors Market Size by Geographic Region (2017-2022)
        4.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Geographic Region
    4.2 World Historic PD-1 and PD-L1 Inhibitors Market Size by Country/Region (2017-2022)
        4.2.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Country/Region (2017-2022)
        4.2.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Country/Region
    4.3 Americas PD-1 and PD-L1 Inhibitors Sales Growth
    4.4 APAC PD-1 and PD-L1 Inhibitors Sales Growth
    4.5 Europe PD-1 and PD-L1 Inhibitors Sales Growth
    4.6 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Growth
5 Americas
    5.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country
        5.1.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)
        5.1.2 Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)
    5.2 Americas PD-1 and PD-L1 Inhibitors Sales by Type
    5.3 Americas PD-1 and PD-L1 Inhibitors Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region
        6.1.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region (2017-2022)
        6.1.2 APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2017-2022)
    6.2 APAC PD-1 and PD-L1 Inhibitors Sales by Type
    6.3 APAC PD-1 and PD-L1 Inhibitors Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe PD-1 and PD-L1 Inhibitors by Country
        7.1.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)
        7.1.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)
    7.2 Europe PD-1 and PD-L1 Inhibitors Sales by Type
    7.3 Europe PD-1 and PD-L1 Inhibitors Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa PD-1 and PD-L1 Inhibitors by Country
        8.1.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)
        8.1.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)
    8.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type
    8.3 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors
    10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
    10.4 Industry Chain Structure of PD-1 and PD-L1 Inhibitors
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 PD-1 and PD-L1 Inhibitors Distributors
    11.3 PD-1 and PD-L1 Inhibitors Customer
12 World Forecast Review for PD-1 and PD-L1 Inhibitors by Geographic Region
    12.1 Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Region
        12.1.1 Global PD-1 and PD-L1 Inhibitors Forecast by Region (2023-2028)
        12.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global PD-1 and PD-L1 Inhibitors Forecast by Type
    12.7 Global PD-1 and PD-L1 Inhibitors Forecast by Application
13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck PD-1 and PD-L1 Inhibitors Product Offered
        13.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 Novartis
        13.2.1 Novartis Company Information
        13.2.2 Novartis PD-1 and PD-L1 Inhibitors Product Offered
        13.2.3 Novartis PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Novartis Main Business Overview
        13.2.5 Novartis Latest Developments
    13.3 Bristol-Myers Squibb
        13.3.1 Bristol-Myers Squibb Company Information
        13.3.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Offered
        13.3.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Bristol-Myers Squibb Main Business Overview
        13.3.5 Bristol-Myers Squibb Latest Developments
    13.4 GlaxoSmithKline
        13.4.1 GlaxoSmithKline Company Information
        13.4.2 GlaxoSmithKline PD-1 and PD-L1 Inhibitors Product Offered
        13.4.3 GlaxoSmithKline PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 GlaxoSmithKline Main Business Overview
        13.4.5 GlaxoSmithKline Latest Developments
    13.5 Regeneron Pharmaceuticals
        13.5.1 Regeneron Pharmaceuticals Company Information
        13.5.2 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Product Offered
        13.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Regeneron Pharmaceuticals Main Business Overview
        13.5.5 Regeneron Pharmaceuticals Latest Developments
    13.6 Eli Lilly and Company
        13.6.1 Eli Lilly and Company Company Information
        13.6.2 Eli Lilly and Company PD-1 and PD-L1 Inhibitors Product Offered
        13.6.3 Eli Lilly and Company PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Eli Lilly and Company Main Business Overview
        13.6.5 Eli Lilly and Company Latest Developments
    13.7 Roche Genetech
        13.7.1 Roche Genetech Company Information
        13.7.2 Roche Genetech PD-1 and PD-L1 Inhibitors Product Offered
        13.7.3 Roche Genetech PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Roche Genetech Main Business Overview
        13.7.5 Roche Genetech Latest Developments
    13.8 AstraZeneca
        13.8.1 AstraZeneca Company Information
        13.8.2 AstraZeneca PD-1 and PD-L1 Inhibitors Product Offered
        13.8.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 AstraZeneca Main Business Overview
        13.8.5 AstraZeneca Latest Developments
    13.9 Jiangsu HengRui Medicine Co., Ltd.
        13.9.1 Jiangsu HengRui Medicine Co., Ltd. Company Information
        13.9.2 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Product Offered
        13.9.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Jiangsu HengRui Medicine Co., Ltd. Main Business Overview
        13.9.5 Jiangsu HengRui Medicine Co., Ltd. Latest Developments
    13.10 Curis Inc.
        13.10.1 Curis Inc. Company Information
        13.10.2 Curis Inc. PD-1 and PD-L1 Inhibitors Product Offered
        13.10.3 Curis Inc. PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Curis Inc. Main Business Overview
        13.10.5 Curis Inc. Latest Developments
    13.11 Aurigene
        13.11.1 Aurigene Company Information
        13.11.2 Aurigene PD-1 and PD-L1 Inhibitors Product Offered
        13.11.3 Aurigene PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Aurigene Main Business Overview
        13.11.5 Aurigene Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Humanized IgG1(Immunoglobulin 1)
    Table 4. Major Players of Humanized IgG4(Immunoglobulin 5)
    Table 5. Major Players of Cytokine
    Table 6. Global PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)
    Table 7. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 8. Global PD-1 and PD-L1 Inhibitors Revenue by Type (2017-2022) & ($ million)
    Table 9. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2017-2022)
    Table 10. Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2017-2022) & (US$/Kg)
    Table 11. Global PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)
    Table 12. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 13. Global PD-1 and PD-L1 Inhibitors Revenue by Application (2017-2022)
    Table 14. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2017-2022)
    Table 15. Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2017-2022) & (US$/Kg)
    Table 16. Global PD-1 and PD-L1 Inhibitors Sales by Company (2020-2022) & (Tons)
    Table 17. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2022)
    Table 18. Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2022)
    Table 20. Global PD-1 and PD-L1 Inhibitors Sale Price by Company (2020-2022) & (US$/Kg)
    Table 21. Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution and Sales Area
    Table 22. Players PD-1 and PD-L1 Inhibitors Products Offered
    Table 23. PD-1 and PD-L1 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global PD-1 and PD-L1 Inhibitors Sales by Geographic Region (2017-2022) & (Tons)
    Table 27. Global PD-1 and PD-L1 Inhibitors Sales Market Share Geographic Region (2017-2022)
    Table 28. Global PD-1 and PD-L1 Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global PD-1 and PD-L1 Inhibitors Sales by Country/Region (2017-2022) & (Tons)
    Table 31. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2017-2022)
    Table 32. Global PD-1 and PD-L1 Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (Tons)
    Table 35. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)
    Table 36. Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)
    Table 38. Americas PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)
    Table 39. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 40. Americas PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)
    Table 41. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 42. APAC PD-1 and PD-L1 Inhibitors Sales by Region (2017-2022) & (Tons)
    Table 43. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2017-2022)
    Table 44. APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2017-2022)
    Table 46. APAC PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)
    Table 47. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 48. APAC PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)
    Table 49. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 50. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (Tons)
    Table 51. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)
    Table 52. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)
    Table 54. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)
    Table 55. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 56. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)
    Table 57. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (Tons)
    Table 59. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)
    Table 63. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)
    Table 65. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Inhibitors
    Table 67. Key Market Challenges & Risks of PD-1 and PD-L1 Inhibitors
    Table 68. Key Industry Trends of PD-1 and PD-L1 Inhibitors
    Table 69. PD-1 and PD-L1 Inhibitors Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. PD-1 and PD-L1 Inhibitors Distributors List
    Table 72. PD-1 and PD-L1 Inhibitors Customer List
    Table 73. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2023-2028) & (Tons)
    Table 74. Global PD-1 and PD-L1 Inhibitors Sales Market Forecast by Region
    Table 75. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (Tons)
    Table 78. Americas PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2023-2028) & (Tons)
    Table 80. APAC PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (Tons)
    Table 82. Europe PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (Tons)
    Table 84. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2023-2028) & (Tons)
    Table 86. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2023-2028) & (Tons)
    Table 90. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Application (2023-2028)
    Table 93. Merck Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 94. Merck PD-1 and PD-L1 Inhibitors Product Offered
    Table 95. Merck PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 96. Merck Main Business
    Table 97. Merck Latest Developments
    Table 98. Novartis Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 99. Novartis PD-1 and PD-L1 Inhibitors Product Offered
    Table 100. Novartis PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 101. Novartis Main Business
    Table 102. Novartis Latest Developments
    Table 103. Bristol-Myers Squibb Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 104. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Offered
    Table 105. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 106. Bristol-Myers Squibb Main Business
    Table 107. Bristol-Myers Squibb Latest Developments
    Table 108. GlaxoSmithKline Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 109. GlaxoSmithKline PD-1 and PD-L1 Inhibitors Product Offered
    Table 110. GlaxoSmithKline PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 111. GlaxoSmithKline Main Business
    Table 112. GlaxoSmithKline Latest Developments
    Table 113. Regeneron Pharmaceuticals Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 114. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Product Offered
    Table 115. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 116. Regeneron Pharmaceuticals Main Business
    Table 117. Regeneron Pharmaceuticals Latest Developments
    Table 118. Eli Lilly and Company Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 119. Eli Lilly and Company PD-1 and PD-L1 Inhibitors Product Offered
    Table 120. Eli Lilly and Company PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 121. Eli Lilly and Company Main Business
    Table 122. Eli Lilly and Company Latest Developments
    Table 123. Roche Genetech Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 124. Roche Genetech PD-1 and PD-L1 Inhibitors Product Offered
    Table 125. Roche Genetech PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 126. Roche Genetech Main Business
    Table 127. Roche Genetech Latest Developments
    Table 128. AstraZeneca Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 129. AstraZeneca PD-1 and PD-L1 Inhibitors Product Offered
    Table 130. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 131. AstraZeneca Main Business
    Table 132. AstraZeneca Latest Developments
    Table 133. Jiangsu HengRui Medicine Co., Ltd. Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 134. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Product Offered
    Table 135. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 136. Jiangsu HengRui Medicine Co., Ltd. Main Business
    Table 137. Jiangsu HengRui Medicine Co., Ltd. Latest Developments
    Table 138. Curis Inc. Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 139. Curis Inc. PD-1 and PD-L1 Inhibitors Product Offered
    Table 140. Curis Inc. PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 141. Curis Inc. Main Business
    Table 142. Curis Inc. Latest Developments
    Table 143. Aurigene Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 144. Aurigene PD-1 and PD-L1 Inhibitors Product Offered
    Table 145. Aurigene PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
    Table 146. Aurigene Main Business
    Table 147. Aurigene Latest Developments
List of Figures
    Figure 1. Picture of PD-1 and PD-L1 Inhibitors
    Figure 2. PD-1 and PD-L1 Inhibitors Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate 2017-2028 (Tons)
    Figure 7. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. PD-1 and PD-L1 Inhibitors Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Humanized IgG1(Immunoglobulin 1)
    Figure 10. Product Picture of Humanized IgG4(Immunoglobulin 5)
    Figure 11. Product Picture of Cytokine
    Figure 12. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2021
    Figure 13. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2017-2022)
    Figure 14. PD-1 and PD-L1 Inhibitors Consumed in Oral
    Figure 15. Global PD-1 and PD-L1 Inhibitors Market: Oral (2017-2022) & (Tons)
    Figure 16. PD-1 and PD-L1 Inhibitors Consumed in Subcutaneous Injection
    Figure 17. Global PD-1 and PD-L1 Inhibitors Market: Subcutaneous Injection (2017-2022) & (Tons)
    Figure 18. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Figure 19. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application in 2021
    Figure 20. PD-1 and PD-L1 Inhibitors Revenue Market by Company in 2021 ($ Million)
    Figure 21. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company in 2021
    Figure 22. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Geographic Region (2017-2022)
    Figure 23. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region in 2021
    Figure 24. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2017-2022)
    Figure 25. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Country/Region in 2021
    Figure 26. Americas PD-1 and PD-L1 Inhibitors Sales 2017-2022 (Tons)
    Figure 27. Americas PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)
    Figure 28. APAC PD-1 and PD-L1 Inhibitors Sales 2017-2022 (Tons)
    Figure 29. APAC PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)
    Figure 30. Europe PD-1 and PD-L1 Inhibitors Sales 2017-2022 (Tons)
    Figure 31. Europe PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)
    Figure 32. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales 2017-2022 (Tons)
    Figure 33. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)
    Figure 34. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021
    Figure 35. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021
    Figure 36. United States PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Canada PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 40. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2021
    Figure 41. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Regions in 2021
    Figure 42. China PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Japan PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 44. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 46. India PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Australia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021
    Figure 49. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021
    Figure 50. Germany PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 51. France PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 52. UK PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Italy PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Russia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021
    Figure 56. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021
    Figure 57. Egypt PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 58. South Africa PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Israel PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 61. GCC Country PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors in 2021
    Figure 63. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
    Figure 64. Industry Chain Structure of PD-1 and PD-L1 Inhibitors
    Figure 65. Channels of Distribution
    Figure 66. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global PD-1 and PD-L1 Inhibitors Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global PD-1 and PD-L1 Inhibitors Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global PD-1 and PD-L1 Inhibitors Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports